127 related articles for article (PubMed ID: 8985782)
1. Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.
Vogel D; Schmidt R; Hartung K; Demuth HU; Chung NN; Schiller PW
Int J Pept Protein Res; 1996 Dec; 48(6):495-502. PubMed ID: 8985782
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
3. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
4. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of cyclic beta-casomorphin-5 analogues.
Schmidt R; Neubert K; Barth A; Liebmann C; Schnittler M; Chung NN; Schiller PW
Peptides; 1991; 12(6):1175-80. PubMed ID: 1667685
[TBL] [Abstract][Full Text] [Related]
6. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
7. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
Chang KJ; Wei ET; Killian A; Chang JK
J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position.
Schiller PW; Nguyen TM; Maziak LA; Wilkes BC; Lemieux C
J Med Chem; 1987 Nov; 30(11):2094-9. PubMed ID: 2822930
[TBL] [Abstract][Full Text] [Related]
9. A novel cyclic opioid peptide analog showing high preference for mu-receptors.
Schiller PW; Nguyen TM; Maziak L; Lemieux C
Biochem Biophys Res Commun; 1985 Mar; 127(2):558-64. PubMed ID: 2983726
[TBL] [Abstract][Full Text] [Related]
10. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
11. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling.
Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL
J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs.
Fichna J; Perlikowska R; Wyrębska A; Gach K; Piekielna J; do-Rego JC; Toth G; Kluczyk A; Janecki T; Janecka A
Bioorg Med Chem; 2011 Dec; 19(23):6977-81. PubMed ID: 22047797
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides.
Schiller PW; Nguyen TM; DiMaio J; Lemieux C
Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885
[TBL] [Abstract][Full Text] [Related]
14. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
[TBL] [Abstract][Full Text] [Related]
15. Topochemical analysis of morphiceptin and dermorphin bioactivities.
Yamazaki T; Ro S; Goodman M
Biochem Biophys Res Commun; 1991 Dec; 181(2):664-70. PubMed ID: 1661586
[TBL] [Abstract][Full Text] [Related]
16. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
17. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
[TBL] [Abstract][Full Text] [Related]
18. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
19. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
20. Ureido group containing cyclic dermorphin(1-7) analogues: synthesis, biology and conformation.
Witkowska E; Nowakowski M; Oleszczuk M; Filip K; Ciszewska M; Chung NN; Schiller PW; Wójcik J; Izdebski J
J Pept Sci; 2007 Aug; 13(8):519-28. PubMed ID: 17605130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
